| Authors: |
Yanada M; Department of Hematology and Oncology, Nagoya City University East Medical Center, Nagoya, 464-8547, Japan. myanada@med.nagoya-cu.ac.jp., Shimomura Y; Kobe City Medical Center General Hospital, Kobe, Japan., Yamasaki S; St. Mary's Hospital, Kurume, Japan., Mizuno S; Aichi Medical University, Nagakute, Japan., Uchida N; Toranomon Hospital, Tokyo, Japan., Doki N; Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan., Fukuda T; National Cancer Center Hospital, Tokyo, Japan., Tanaka M; Kanagawa Cancer Center, Yokohama, Japan., Nishida T; Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan., Eto T; Hamanomachi Hospital, Fukuoka, Japan., Katayama Y; Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital, Hiroshima, Japan., Yoshihara S; Hyogo Medical University Hospital, Nishinomiya, Japan., Ota S; Sapporo Hokuyu Hospital, Sapporo, Japan., Hasegawa Y; Hokkaido University Hospital, Sapporo, Japan., Onizuka M; Tokai University School of Medicine, Isehara, Japan., Kawakita T; National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan., Sawa M; Anjo Kosei Hospital, Anjo, Japan., Kawamura K; Tottori University Hospital, Yonago, Japan., Kanda J; Kyoto University Hospital, Kyoto, Japan., Atsuta Y; Aichi Medical University, Nagakute, Japan.; Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan., Konuma T; The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. |